VENABLE LLP

Lobbying for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA · Non-profit product development partnership

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · Senate · $10,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Budget/Appropriations

FY 2027 Labor, Health and Human Services, Education and State and Foreign Operations funding for global health research and development and neglected tropical diseases; FY 2027 global health research and development funding; Issues related to global health.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.